Result of General Meeting

RNS Number : 3724L

Omega Diagnostics Group PLC

18 July 2017

 

18 July 2017

Omega Diagnostics Group plc

Result of General Meeting

Further to Omega's announcement of 30 June 2017, the Company is pleased to announce today the passing of the Resolutions at the General Meeting held earlier today. The Placing, Subscription and Open Offer remain conditional on Admission of the New Ordinary Shares to AIM which is expected to take place at 8.00 a.m. tomorrow.

With effect from Admission the Company will have 126,884,060 Ordinary Shares in issue, with no shares held in treasury. Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 30 June 2017.

Contacts:

Omega Diagnostics Group PLC	Tel: [phone]
Andrew Shepherd, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: [phone]
Geoff Nash/James Thompson (Corporate Finance)
Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

1.	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	David Evans
2.	Reason for notification
b)	Position / status	Non-Executive Chairman
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Acquisition of shares pursuant to the Placing
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.18 1,111,111
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	19 July 2017
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

1.	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Andrew Shepherd
2.	Reason for notification
b)	Position / status	Chief Executive Officer
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Acquisition of shares pursuant to the Placing
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.18 111,111
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	19 July 2017
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

1.	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Kieron Harbinson
2.	Reason for notification
b)	Position / status	Finance Director
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Acquisition of shares pursuant to the Placing
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.18 55,555
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	19 July 2017
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

1.	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Jag Grewal
2.	Reason for notification
b)	Position / status	Sales & Marketing Director
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Acquisition of shares pursuant to the Placing
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.18 53,333
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	19 July 2017
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

1.	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Colin King
2.	Reason for notification
b)	Position / status	Chief Operating Officer
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Acquisition of shares pursuant to the Placing
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.18 277,777
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	19 July 2017
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

 

END

 

 

ROMKVLBFDDFXBBB